WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 7'7601 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 20'3291 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 7'085  7'131  7'177  7'222  7'266  7'998  8'841  8'879 
Births 66  66  67  68  69  65  105  133 
Surviving infants 65  66  66  67  68  64  103  130 
Pop. less than 5 years 320  324  336  341  348  322  558  680 
Pop. less than 15 years 1'009  1'005  1'005  998  992  1'252  1'799  1'967 
Female 15-49 years 1'525  1'547  1'569  1'593  1'618  1'938  2'110  2'145 

Number of reported cases

(Click for retrospective incidence data for Bulgaria)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  165  14  46  147  10'763 
Mumps
ChartChart
  15  19  18  31  25  2'357 
Pertussis
ChartChart
  116  98  35  52  89  106  26  154 
Polio*
ChartChart
  15 
Rubella
ChartChart
  10  28'449 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  18 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bulgaria)
Vaccine year result method % card seen                                                
BCG          96  96  96  97  97  98 
DTP1          96  94  93  90  96  95 
DTP3          92  92  91  88  95  93 
DTP4          93  90  65  78 
IPV1          96  94  93  90 
HepB_BD          97  96  97  98  98  98 
HepB3          92  91  92  95  95  94 
Hib3          92  92  87  83  95  90 
JapEnc         
MCV1          94  92  92  93  95  89 
MCV2          92  88  87  89  94  83 
MenA         
PCV1          95  94  95  95  96 
PCV2          94  93  93  94  95 
PCV3          91  90  90  92  94 
Pol3          92  92  91  88  95  94 
Rota1         
RotaC         
RCV1          94  92  92  93  95 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bulgaria)
BCG
ChartChart
  96  96  96  97  97  98  99  99 
DTP1
ChartChart
  96  94  93  90  96  95  99  98 
DTP3
ChartChart
  92  92  91  88  95  93  99  98 
HepB3
ChartChart
  92  91  92  95  95  94 
HepB_BD
ChartChart
  97  96  97  98  98  98 
Hib3
ChartChart
  92  92  87  83  95 
MCV1
ChartChart
  94  92  92  93  95  89  99  98 
MCV2
ChartChart
  92  88  87  89  94  83 
PCV3
ChartChart
  91  90  90  92  94 
Pol3
  92  92  91  88  95  94  99  99 
RCV1
ChartChart
  94  92  92  93  95  89 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 28  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
200 
   
/
|
|
\
Greater or equal to 90% 86
From 80 to 89% 14
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; 7 months; 7, 11, 17 years; Yes
DTaPHibHepBIPV 2, 3, 4 months; Yes
DTaPHibHepIPV 2, 3, 4 months; Yes
DTaPHibIPV 2, 3, 4, 16 months; Yes
DTaPIPV 6 years; Yes
HepB_Pediatric birth; 1, 6 months;
Influenza_Adult Yes elderly, chronic illness, HCWs, residents living in long-term care facilities, other risk groups
Influenza_Pediatric Yes children with chronic illness
MMR 13 months; 12 years; Yes
Pneumo_conj 2, 3, 4, 12 months; Yes
Rabies Yes as post-exposure prophylaxis
Td 12, 17, 25, 35, 45, 55 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   28  28  28  28  28  28 

System performance

Total Nº districts in country number 28  28  28  28  28  28  28 
Nº districts with DTP3 coverage >=80% number 28  26  26  23  28  28  28 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  93  93  82  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 15  12  14  16  13  13 
% of districts with MCV1 coverage >=95% From 0 to 100% 54  43  32  50  57  46  46 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%           100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  NA 

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.